Thus, VEGF-C appears to be a diagnostic marker and therapeutic target for RA therapy; therapeutic agents that directly or indirectly regulate VEGF-C activity may prove promising in the treatment of RA disease. Here, VEGFC is linked to rheumatoid arthritis.